<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1012</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-10-58-62</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Pharmaceutical industry in the ﬁrst half of 2020</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>Svetlana</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2020-12-10" publication-format="electronic"><day>10</day><month>12</month><year>2020</year></pub-date><issue>10</issue><fpage>58</fpage><lpage>62</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>The analysis of pharmaceutical enterprises is performed using the data of the state statistical reporting of the industry enterprises. According to Rosstat, the quantum index by type of economic activity with code 21. 2: “Manufacture of drug products and materials used for medical purposes” for the first half of the year was at the level of 115.8% compared to the same period of the previous year, and 161.2% compared to code 21.1: “Manufacture of pharmaceutical substances”.</abstract><kwd-group xml:lang="en"><kwd>pharmaceutical industry</kwd><kwd>medical industry</kwd><kwd>medical products</kwd><kwd>drugs</kwd><kwd>pharmacotherapeutic groups</kwd><kwd>pharmaceutical substances</kwd><kwd>analysis</kwd><kwd>release indicators</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фармацевтическая промышленность</kwd><kwd>медицинская промышленность</kwd><kwd>медицинская продукция</kwd><kwd>лекарственные средства</kwd><kwd>фармакотерапевтические группы</kwd><kwd>фармацевтические субстанции</kwd><kwd>анализ</kwd><kwd>показатели выпуска</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Королев М.А., Фигурнов Э.Б. Статистика и экономический анализ в управлении народным хозяйством. М.: Экономика; 1985.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Романова С.А. Ежемесячный обзор: производство, инвестиции, финансы. Ремедиум. 2019;(9):54-68.</mixed-citation></ref></ref-list></back></article>
